Reed Gastrointestional Oncology Research Foundation

Analysis

Reed Gastrointestional Oncology Research Foundation is a registered charity in United States, based in Birmingham, AL. It received its IRS tax-exemption ruling in April 2003, 23 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Reed Gastrointestional Oncology Research Foundation reported income of $236k and spending of $228k, spending 96% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $201k to $236k (+18%), an average of +4.2% a year. The sharpest change came in the year to December 2023, when income rose by 77%. Over the whole period it spent 121% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Reed Gastrointestional Oncology Research Foundation sits at the 43rd percentile: it is larger than about 43% of them. Against every charity in United States with reported income it ranks in the 57th percentile, and in the 58th percentile within AL. Charities of a similar size with the same main cause include Friends with Diabetes Internationalinc ($236k), Karen Collins Un-Teal There Is a Cure ($236k) and Central Valley Veterans ($236k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 147% of the total. Compensation of current officers, directors and key employees was $75k (33% of expenses). At year end it held assets of $485k against liabilities of $5,111, net assets of $480k.